scholarly journals Incidence, Determinants, and Prognostic Significance of Hyperkalemia and Worsening Renal Function in Patients With Heart Failure Receiving the Mineralocorticoid Receptor Antagonist Eplerenone or Placebo in Addition to Optimal Medical Therapy

2014 ◽  
Vol 7 (1) ◽  
pp. 51-58 ◽  
Author(s):  
Patrick Rossignol ◽  
Daniela Dobre ◽  
John J.V. McMurray ◽  
Karl Swedberg ◽  
Henry Krum ◽  
...  
Keyword(s):  
Heart Failure ◽  
Renal Function ◽  
Receptor Antagonist ◽  
Medical Therapy ◽  
Mineralocorticoid Receptor ◽  
Prognostic Significance ◽  
Optimal Medical Therapy ◽  
Mineralocorticoid Receptor Antagonist ◽  
Worsening Renal Function ◽  
Patients With Heart Failure

scholarly journals Effects of mineralocorticoid receptor antagonist spironolactone on atrial conduction and remodeling in patients with heart failure

2011 ◽  
Vol 57 (2) ◽  
pp. 208-214 ◽  
Author(s):  
Masayasu Kimura ◽  
Hiroshi Ogawa ◽  
Takatoshi Wakeyama ◽  
Akira Takaki ◽  
Takahiro Iwami ◽  
...  
Keyword(s):  
Heart Failure ◽  
Receptor Antagonist ◽  
Mineralocorticoid Receptor ◽  
Mineralocorticoid Receptor Antagonist ◽  
Patients With Heart Failure

scholarly journals Consistency of Laboratory Monitoring During Initiation of Mineralocorticoid Receptor Antagonist Therapy in Patients With Heart Failure

JAMA ◽  
2015 ◽  
Vol 314 (18) ◽  
pp. 1973 ◽  
Author(s):  
Lauren B. Cooper ◽  
Bradley G. Hammill ◽  
Eric D. Peterson ◽  
Bertram Pitt ◽  
Matthew L. Maciejewski ◽  
...  
Keyword(s):  
Heart Failure ◽  
Receptor Antagonist ◽  
Mineralocorticoid Receptor ◽  
Laboratory Monitoring ◽  
Mineralocorticoid Receptor Antagonist ◽  
Antagonist Therapy ◽  
Patients With Heart Failure
Sign in / Sign up

Export Citation Format

Share Document